Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Oct 23, 2024$14.33
P/E Ratio
N/A
Market Cap
$1.26B
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.
Overview
Trading Information
Company